Pearl Shirley Huang
Fortune : 765 457 $ au 30/06/2026
Fortune : 765 457 $ au 30/06/2026
Pearl Shirley Huang was the founder of BeOne Medicines Ltd., founded in 2010, where the title held was Chief Scientific Officer from 2010 to 2012.
Current jobs include Chief Executive Officer at Dunad Therapeutics Ltd. since 2022, Director at BB Biotech AG since 2022, Independent Director at Waters Corp.
since 2021, and Director at MIT Corp.
(United States).
Former jobs include President, Chief Executive Officer & Director at Cygnal Therapeutics, Inc. from 2019 to 2022, Chairman at RICC A, Director at KSQ Therapeutics, Inc. from 2019 to 2022, Senior VP & Global Head-Therapeutic Modalities at F.
Hoffmann-La Roche Ltd. from 2014 to 2018, Vice President at GSK Plc from 2012 to 2014, and Advisor Partner at Flagship Pioneering, LLC.
Education includes undergraduate studies at Massachusetts Institute of Technology and a doctorate from Princeton University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/03/2026 | 2 041 ( 0% ) | 765 457 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| WATERS CORPORATION | Directeur/Membre du Conseil | 01/01/2021 |
| BB BIOTECH AG | Directeur/Membre du Conseil | 17/03/2022 |
MIT Corp. (United States)
MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Directeur/Membre du Conseil | - |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Develops oral protein degradation therapies | Directeur Général | 28/06/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Directeur/Membre du Conseil | 23/09/2022 |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops drugs for treatments of cancer, immune-inflammatory disorders, fibrotic and degenerative diseases | Directeur Général | 18/05/2022 |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Consultant / Advisor | 30/04/2022 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/12/2018 |
| GSK PLC | Corporate Officer/Principal | 01/01/2014 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
BB Biotech AG
BB Biotech AG Financial ConglomeratesFinance Provides investment services for biotechnology sector | Finance |
Waters Corp.
Waters Corp. Medical SpecialtiesHealth Technology Designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy, and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
MIT Corp. (United States)
MIT Corp. (United States) Other Consumer ServicesConsumer Services MIT Corp. (US) owns and operates as a trust. The corporation and its committees have responsibility for reviewing and providing guidance on strategic directions, approving annual budgets and exercising long-term fiduciary responsibility. The company was founded in 1861 and is headquartered in Cambridge, MA. | Consumer Services |
BeiGene Ltd.
BeiGene Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
KSQ Therapeutics, Inc.
KSQ Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops therapeutics for cancer | Health Technology |
Cygnal Therapeutics, Inc.
Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops drugs for treatments of cancer, immune-inflammatory disorders, fibrotic and degenerative diseases | Health Technology |
Dunad Therapeutics Ltd.
Dunad Therapeutics Ltd. BiotechnologyHealth Technology Develops oral protein degradation therapies | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national